Lisata Therapeutics CEO David Mazzo on ASCEND and iLSTA trial results

By Proactive Investors / January 23, 2025 / www.youtube.com / Article Link

Lisata Therapeutics Inc (NASDAQ:LSTA) CEO David Mazzo joined Proactive's Stephen Gunnion with an update on the company's ...

Recent News

AOCE and WB boost gold targets for 2025 significantly

November 10, 2025 / www.canadianminingreport.com

Gold and silver price ETFs see major net outflows

November 04, 2025 / canadianminingreport.com

Gold stocks decline by less than metal price

November 04, 2025 / www.canadianminingreport.com

A shift to the later stages of gold and silver bull markets

October 27, 2025 / www.canadianminingreport.com

Gold stocks plunge on metal drop

October 27, 2025 / www.canadianminingreport.com

See all >